EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mass spectrometry imaging of hair identifies daily maraviroc adherence in HPTN 069/ACTG A5305

Elias P Rosen iD, Nicole White, William M Gilliland, Roy R Gerona, Monica Gandhi, K Rivet Amico, Kenneth H Mayer, Roy M Gulick, Angela D M Kashuba

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0287449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Elias P Rosen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Eshelman School of Pharmacy, University of North Carolina at Chapel Hill at Chapel Hill, Chapel Hill, North Carolina, United States of America. Hauptthemen laut MEDLINE: HIV Infections, Pre-Exposure Prophylaxis, Anti-HIV Agents. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Allergy and Infectious Diseases, AIDS Clinical Trial Group.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective measures of adherence for antiretrovirals used as pre-exposure prophylaxis (PrEP) are critical for improving preventative efficacy in both clinical trials and real-world application. Current objective adherence measures either reflect only recent behavior (eg days for plasma or urine) or cumulative behavior (eg months for dried blood spots). Here, we measured the accumulation of the antiretroviral drug maraviroc (MVC) in hair strands by infrared matrix-assisted laser desorption electrospray ionization (IR-MALDESI) mass spectrometry imaging (MSI) to evaluate adherence behavior longitudinally at high temporal resolution. An MSI threshold for classifying daily adherence was established using clinical samples from healthy volunteers following directly observed dosing of 1 to 7 doses MVC/week. We then used the benchmarked MSI assay to classify adherence to MVC-based PrEP regimens in hair samples collected throughout the 48-week HPTN069/ACTGA5305 study. We found that only ~32% of investigated hair samples collected during the study’s active dosing period showed consistent daily PrEP adherence throughout a retrospective period of 30 days, and also found that profiles of daily individual adherence from MSI hair analysis could identify when patients were and were not taking study drug. The assessment of adherence from MSI hair strand analysis was 62% lower than adherence classified using paired plasma samples, the latter of which may be influenced by white-coat adherence. These findings demonstrate the ability of MSI hair analysis to examine daily variability of adherence behavior over a longer-term measurement and offer the potential for longitudinal comparison with risk behavior to target patient-specific adherence interventions and improve outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsPre-Exposure ProphylaxisAnti-HIV AgentsHumansMaravirocRetrospective StudiesAnti-Retroviral AgentsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationHairMedication Adherence

Substanzen

MaravirocAnti-Retroviral AgentsAnti-HIV Agents

Autor:innen und Institutionen

  • Eshelman School of Pharmacy, University of North Carolina at Chapel Hill at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Department of Chemistry, Furman University, Greenville, South Carolina, United States of America.
  • Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, California, United States of America.
  • Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
  • School of Public Health, University of Michigan, Ann Arbor, Michigan, United States of America.
  • Fenway Health, Department of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, United States of America.

ORCID-Profile: Elias P Rosen

Förderung

  • NIAID NIH HHS
  • National Institutes of Allergy and Infectious Diseases
  • AIDS Clinical Trial Group
  • HIV Prevention Trial Network

Zitieren

APA

Rosen, E. P., White, N., Gilliland, W. M., Gerona, R. R., Gandhi, M., Amico, K. R., Mayer, K. H., Gulick, R. M., & Kashuba, A. D. M. (2023). Mass spectrometry imaging of hair identifies daily maraviroc adherence in HPTN 069/ACTG A5305. PLOS ONE. https://doi.org/10.1371/journal.pone.0287449

Vancouver

Rosen EP, White N, Gilliland WM, Gerona RR, Gandhi M, Amico KR, et al. Mass spectrometry imaging of hair identifies daily maraviroc adherence in HPTN 069/ACTG A5305. PLOS ONE. 2023. doi:10.1371/journal.pone.0287449

BibTeX
@article{Rosen2023,
  author = {Rosen, Elias P and White, Nicole and Gilliland, William M and Gerona, Roy R and Gandhi, Monica and Amico, K Rivet and Mayer, Kenneth H and Gulick, Roy M and Kashuba, Angela D M},
  title = {Mass spectrometry imaging of hair identifies daily maraviroc adherence in HPTN 069/ACTG A5305},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0287449}
}
Kostenlos starten →